Literature DB >> 31172216

Pancreatic beta cells persistently infected with coxsackievirus B4 are targets of NK cell-mediated cytolytic activity.

Magloire Pandoua Nekoua1,2, Antoine Bertin1, Famara Sane1, Enagnon Kazali Alidjinou1, Delphine Lobert1, Jacques Trauet3, Christine Hober4, Ilka Engelmann1, Kabirou Moutairou2, Akadiri Yessoufou2, Didier Hober5,6.   

Abstract

It has been suggested that the persistence of coxsackieviruses-B (CV-B) in pancreatic beta cells plays a role in the pathogenesis of type 1 diabetes (T1D). Yet, immunological effectors, especially natural killer (NK) cells, are supposed to clear virus-infected cells. Therefore, an evaluation of the response of NK cells to pancreatic beta cells persistently infected with CV-B4 was conducted. A persistent CV-B4 infection was established in 1.1B4 pancreatic beta cells. Infectious particles were found in supernatants throughout the culture period. The proportion of cells containing viral protein VP1 was low (< 5%), although a large proportion of cells harbored viral RNA (around 50%), whilst cell viability was preserved. HLA class I cell surface expression was downregulated in persistently infected cultures, but HLA class I mRNA levels were unchanged in comparison with mock-infected cells. The cytolytic activities of IL-2-activated non-adherent peripheral blood mononuclear cells (PBMCs) and of NK cells were higher towards persistently infected cells than towards mock-infected cells, as assessed by an LDH release assay. Impaired cytolytic activity of IL-2-activated non-adherent PBMCs from patients with T1D towards infected beta cells was observed. In conclusion, pancreatic beta cells persistently infected with CV-B4 can be lysed by NK cells, implying that impaired cytolytic activity of these effector cells may play a role in the persistence of CV-B in the host and thus in the viral pathogenesis of T1D.

Entities:  

Keywords:  Enterovirus; HLA class I; LDH assay; Persistence; Type 1 diabetes

Mesh:

Year:  2019        PMID: 31172216     DOI: 10.1007/s00018-019-03168-4

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  66 in total

Review 1.  Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation.

Authors:  Barbara Seliger; Ulrike Ritz; Soldano Ferrone
Journal:  Int J Cancer       Date:  2006-01-01       Impact factor: 7.396

Review 2.  Natural killer cells in antiviral defense: function and regulation by innate cytokines.

Authors:  C A Biron; K B Nguyen; G C Pien; L P Cousens; T P Salazar-Mather
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

3.  Effects of foot-and-mouth disease virus nonstructural proteins on the structure and function of the early secretory pathway: 2BC but not 3A blocks endoplasmic reticulum-to-Golgi transport.

Authors:  Katy Moffat; Gareth Howell; Caroline Knox; Graham J Belsham; Paul Monaghan; Martin D Ryan; Thomas Wileman
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation: analysis of the surface expression and function of activating NK receptors.

Authors:  Chiara Vitale; Laura Chiossone; Giuseppe Morreale; Edoardo Lanino; Francesca Cottalasso; Sara Moretti; Giorgio Dini; Lorenzo Moretta; Maria Cristina Mingari
Journal:  Mol Immunol       Date:  2005-02       Impact factor: 4.407

5.  Coxsackievirus B4 can infect human pancreas ductal cells and persist in ductal-like cell cultures which results in inhibition of Pdx1 expression and disturbed formation of islet-like cell aggregates.

Authors:  Famara Sane; Delphine Caloone; Valéry Gmyr; Ilka Engelmann; Sandrine Belaich; Julie Kerr-Conte; François Pattou; Rachel Desailloud; Didier Hober
Journal:  Cell Mol Life Sci       Date:  2013-06-18       Impact factor: 9.261

6.  Cultured human myocardial fibroblasts of pediatric origin: natural human interferon-alpha is more effective than recombinant interferon-alpha 2a in carrier-state coxsackievirus B3 replication.

Authors:  A Heim; C Brehm; M Stille-Siegener; G Müller; S Hake; R Kandolf; H R Figulla
Journal:  J Mol Cell Cardiol       Date:  1995-10       Impact factor: 5.000

7.  Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients.

Authors:  Francesco Dotta; Stefano Censini; Astrid G S van Halteren; Lorella Marselli; Matilde Masini; Sabrina Dionisi; Franco Mosca; Ugo Boggi; Andrea Onetti Muda; Stefano Del Prato; John F Elliott; Antonello Covacci; Rino Rappuoli; Bart O Roep; Piero Marchetti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-14       Impact factor: 11.205

8.  Evidence that the reduced number of natural killer cells in type 1 (insulin-dependent) diabetes may be genetically determined.

Authors:  M J Hussain; L Alviggi; B A Millward; R D Leslie; D A Pyke; D Vergani
Journal:  Diabetologia       Date:  1987-12       Impact factor: 10.122

9.  Natural killer cells from children with type 1 diabetes have defects in NKG2D-dependent function and signaling.

Authors:  Huilian Qin; I-Fang Lee; Constadina Panagiotopoulos; Xiaoxia Wang; Alvina D Chu; Paul J Utz; John J Priatel; Rusung Tan
Journal:  Diabetes       Date:  2011-01-26       Impact factor: 9.461

10.  Enterovirus RNA in blood is linked to the development of type 1 diabetes.

Authors:  Sami Oikarinen; Mika Martiskainen; Sisko Tauriainen; Heini Huhtala; Jorma Ilonen; Riitta Veijola; Olli Simell; Mikael Knip; Heikki Hyöty
Journal:  Diabetes       Date:  2010-10-13       Impact factor: 9.461

View more
  8 in total

Review 1.  Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus.

Authors:  Magloire Pandoua Nekoua; Enagnon Kazali Alidjinou; Didier Hober
Journal:  Nat Rev Endocrinol       Date:  2022-06-01       Impact factor: 47.564

2.  Coxsackievirus B Persistence Modifies the Proteome and the Secretome of Pancreatic Ductal Cells.

Authors:  Niina Lietzén; Karoliina Hirvonen; Anni Honkimaa; Tanja Buchacher; Jutta E Laiho; Sami Oikarinen; Magdalena A Mazur; Malin Flodström-Tullberg; Eric Dufour; Amir-Babak Sioofy-Khojine; Heikki Hyöty; Riitta Lahesmaa
Journal:  iScience       Date:  2019-07-29

Review 3.  NK Cells in Autoimmune Diseases: Protective or Pathogenic?

Authors:  Meifang Liu; Shujuan Liang; Cai Zhang
Journal:  Front Immunol       Date:  2021-03-12       Impact factor: 7.561

Review 4.  Regulation of Pancreatic β-Cell Mass by Gene-Environment Interaction.

Authors:  Shun-Ichiro Asahara; Hiroyuki Inoue; Yoshiaki Kido
Journal:  Diabetes Metab J       Date:  2022-01-27       Impact factor: 5.376

5.  Transcriptional networks in at-risk individuals identify signatures of type 1 diabetes progression.

Authors:  Louis-Pascal Xhonneux; Oliver Knight; Åke Lernmark; Ezio Bonifacio; William A Hagopian; Marian J Rewers; Jin-Xiong She; Jorma Toppari; Hemang Parikh; Kenneth G C Smith; Anette-G Ziegler; Beena Akolkar; Jeffrey P Krischer; Eoin F McKinney
Journal:  Sci Transl Med       Date:  2021-03-31       Impact factor: 19.319

Review 6.  Structures and Functions of Viral 5' Non-Coding Genomic RNA Domain-I in Group-B Enterovirus Infections.

Authors:  Marie Glenet; Laetitia Heng; Domitille Callon; Anne-Laure Lebreil; Paul-Antoine Gretteau; Yohan Nguyen; Fatma Berri; Laurent Andreoletti
Journal:  Viruses       Date:  2020-08-21       Impact factor: 5.048

7.  Persistence of Coxsackievirus B4 in Pancreatic β Cells Disturbs Insulin Maturation, Pattern of Cellular Proteins, and DNA Methylation.

Authors:  Magloire Pandoua Nekoua; Antoine Bertin; Famara Sane; Jean-Pascal Gimeno; Isabelle Fournier; Michel Salzet; Ilka Engelmann; Enagnon Kazali Alidjinou; Didier Hober
Journal:  Microorganisms       Date:  2021-05-22

8.  Investigation of the utility of the 1.1B4 cell as a model human beta cell line for study of persistent enteroviral infection.

Authors:  Jessica R Chaffey; Jay Young; Kaiyven A Leslie; Katie Partridge; Pouria Akhbari; Shalinee Dhayal; Jessica L Hill; Kyle C A Wedgwood; Edward Burnett; Mark A Russell; Sarah J Richardson; Noel G Morgan
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.